Plant-derived EpCAM-Fc fusion proteins induce in vivo immune response to produce IgGs inhibiting invasion and migration of colorectal cancer cells

Plant Cell Rep. 2024 Dec 4;43(12):302. doi: 10.1007/s00299-024-03377-7.

Abstract

Transgenic tobacco plant expressed EpCAM-Fc fusion proteins to induce in vivo immune responses producing anti-EpCAM antibodies inhibiting human colorectal cancer cell invasion and migration. Plant is emerging as a promising alternative to produce valuable immunotherapeutic vaccines. In this study, we examined the in vivo anti-cancer efficacy of epidermal cell adhesion molecule (EpCAM)-Fc and EpCAM-FcK fusion proteins produced in transgenic plants as colorectal cancer vaccine candidates. Mice were injected with plant-derived EpCAM-Fc (EpCAM-FcP) and EpCAM-FcP tagged with KDEL (ER retention signal) (EpCAM-FcKP), using mammalian-derived EpCAM-Fc (EpCAM-FcM) as positive control. Total IgGs from the immunized mice were used to assess immune responses. ELISA tests revealed that IgGs from mice immunized with EpCAM-FcKP (EpCAM-FcKP IgG) exhibited the highest absorbance value for binding affinity to recombinant EpCAM-FcM compared to IgGs from mice immunized with EpCAM-FcP (EpCAM-FcP IgG) and EpCAM-FcM (EpCAM-FcM IgG). Bio-layer interferometry revealed that EpCAM-FcKP IgG had a higher affinity value than EpCAM-FcM IgG and EpCAM-FcP IgG. Cell ELISA revealed that EpCAM-FcKP IgG exhibited the highest binding activity to EpCAM-positive cells SW480 and SW620 compared to EpCAM-FcP IgG, EpCAM-FcM IgG, and anti-EpCAM mAb. In the transwell invasion assay, EpCAM-FcKP IgG significantly decreased the numbers of invaded SW480 and SW620 cells compared to EpCAM-FcP IgG, whereas EpCAM-FcM IgG had similar numbers. In the wound healing assay, EpCAM-FcKP IgG showed higher migration inhibition compared to EpCAM-FcP IgG in both cell types, with similar results to EpCAM-FcM IgG in SW620 cells. These results confirm the applicability of plant systems to produce EpCAM-Fc vaccine candidates, inducing the production of anti-EpCAM IgGs against colorectal cancer cells.

Keywords: Colorectal cancer; EpCAM-Fc fusion protein; GA733; IgG; Immune response; Plant; Vaccine.

MeSH terms

  • Animals
  • Cancer Vaccines / immunology
  • Cell Line, Tumor
  • Cell Movement*
  • Colorectal Neoplasms* / immunology
  • Colorectal Neoplasms* / pathology
  • Epithelial Cell Adhesion Molecule* / immunology
  • Epithelial Cell Adhesion Molecule* / metabolism
  • Female
  • Humans
  • Immunoglobulin Fc Fragments / genetics
  • Immunoglobulin Fc Fragments / immunology
  • Immunoglobulin Fc Fragments / metabolism
  • Immunoglobulin G* / immunology
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Invasiveness
  • Nicotiana* / genetics
  • Nicotiana* / immunology
  • Nicotiana* / metabolism
  • Plants, Genetically Modified
  • Recombinant Fusion Proteins* / immunology

Substances

  • Epithelial Cell Adhesion Molecule
  • Immunoglobulin G
  • Recombinant Fusion Proteins
  • Immunoglobulin Fc Fragments
  • Cancer Vaccines